Arcadia Biosciences, Inc. - 8-K Filing
Arcadia Biosciences reports Q3 2026 revenue of $1.6M, a 24% year-over-year increase driven by Zola brand growth. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $RKDA